147 related articles for article (PubMed ID: 38172403)
1. Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study.
Nagaoka K; Iwanaga N; Takegoshi Y; Murai Y; Kawasuji H; Miura M; Sato Y; Hatakeyama Y; Ito H; Kato Y; Shibayama N; Terasaki Y; Fujimura T; Takazono T; Kosai K; Sugano A; Morinaga Y; Yanagihara K; Mukae H; Yamamoto Y
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):459-467. PubMed ID: 38172403
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotype of anaerobic bacteremia unaccompanied by detectable abscess lesion: a 10-year retrospective, multicenter, observational-cohort study.
Nagaoka K; Iwanaga N; Murai Y; Kawasuji H; Miura M; Sato Y; Ito H; Terasaki Y; Takazono T; Kosai K; Sugano A; Morinaga Y; Yanagihara K; Mukae H; Yamamoto Y
Infection; 2024 May; ():. PubMed ID: 38767831
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
4. Initial indicators for the prognosis of Acinetobacter Baumannii bacteremia in children.
Hong Y; Lin X; Zhang C; Dong X; Lu M; Huang S; Huang L; Su C; Bai Z; Wu S
BMC Infect Dis; 2023 Sep; 23(1):640. PubMed ID: 37775747
[TBL] [Abstract][Full Text] [Related]
5. Early Intravenous Colistin Therapy as a Favorable Prognostic Factor for 28-day Mortality in Patients with CRAB Bacteremia: a Multicenter Propensity Score-Matching Analysis.
Kim T; Park KH; Yu SN; Park SY; Park SY; Lee YM; Jeon MH; Choo EJ; Kim TH; Lee MS; Lee E
J Korean Med Sci; 2019 Oct; 34(39):e256. PubMed ID: 31602826
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and outcome of anaerobic bacteremia in a tertiary hospital.
Zouggari Y; Lelubre C; Lali SE; Cherifi S
Eur J Intern Med; 2022 Nov; 105():63-68. PubMed ID: 36055955
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and outcomes of Clostridium perfringens bacteremia--a 10-year experience at a tertiary care hospital.
Yang CC; Hsu PC; Chang HJ; Cheng CW; Lee MH
Int J Infect Dis; 2013 Nov; 17(11):e955-60. PubMed ID: 23578849
[TBL] [Abstract][Full Text] [Related]
8. Eubacterium bacteremia - a retrospective observational study of a seldom found anaerobic pathogen.
Bläckberg A; Holm K; Liderot K; Nilson B; Sunnerhagen T
Diagn Microbiol Infect Dis; 2024 Apr; 108(4):116185. PubMed ID: 38232640
[TBL] [Abstract][Full Text] [Related]
9. [Bacteremia caused by anaerobes: analysis of 131 episodes].
Ramos JM; García-Corbeira P; Fernández-Roblas R; Soriano F
Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):9-16. PubMed ID: 8155764
[TBL] [Abstract][Full Text] [Related]
10. Advanced Age is not a Risk Factor for Mortality in Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Organisms: a Multicenter Cohort Study.
Mitsuboshi S; Tsuruma N; Watanabe K; Takahashi S; Ito A; Nakashita M; Suzuki M; Kobayashi K; Tsugita M
Jpn J Infect Dis; 2020 Jul; 73(4):288-292. PubMed ID: 32115542
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
[TBL] [Abstract][Full Text] [Related]
12. Are incidence and epidemiology of anaerobic bacteremia really changing?
Vena A; Muñoz P; Alcalá L; Fernandez-Cruz A; Sanchez C; Valerio M; Bouza E
Eur J Clin Microbiol Infect Dis; 2015 Aug; 34(8):1621-9. PubMed ID: 26017663
[TBL] [Abstract][Full Text] [Related]
13. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
14. Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia.
Wu PS; Chuang C; Wu PF; Lin YT; Wang FD
BMC Infect Dis; 2018 Jun; 18(1):277. PubMed ID: 29902981
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics associated with mortality of patients with anaerobic bacteremia.
Umemura T; Hamada Y; Yamagishi Y; Suematsu H; Mikamo H
Anaerobe; 2016 Jun; 39():45-50. PubMed ID: 26903282
[TBL] [Abstract][Full Text] [Related]
16. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
[TBL] [Abstract][Full Text] [Related]
17. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
Suzuki H; Hase R; Otsuka Y; Hosokawa N
J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.
Wang M; Earley M; Chen L; Hanson BM; Yu Y; Liu Z; Salcedo S; Cober E; Li L; Kanj SS; Gao H; Munita JM; Ordoñez K; Weston G; Satlin MJ; Valderrama-Beltrán SL; Marimuthu K; Stryjewski ME; Komarow L; Luterbach C; Marshall SH; Rudin SD; Manca C; Paterson DL; Reyes J; Villegas MV; Evans S; Hill C; Arias R; Baum K; Fries BC; Doi Y; Patel R; Kreiswirth BN; Bonomo RA; Chambers HF; Fowler VG; Arias CA; van Duin D;
Lancet Infect Dis; 2022 Mar; 22(3):401-412. PubMed ID: 34767753
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for mortality in patients with Serratia marcescens bacteremia.
Kim SB; Jeon YD; Kim JH; Kim JK; Ann HW; Choi H; Kim MH; Song JE; Ahn JY; Jeong SJ; Ku NS; Han SH; Choi JY; Song YG; Kim JM
Yonsei Med J; 2015 Mar; 56(2):348-54. PubMed ID: 25683980
[TBL] [Abstract][Full Text] [Related]
20. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance.
Lombardi DP; Engleberg NC
Am J Med; 1992 Jan; 92(1):53-60. PubMed ID: 1731510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
